For Immediate Release


March 2007 – A potential treatment using AndroScience’s compound, ASC-J9^®, for a neurodegenerative disorder is published in
Nature Medicine

A report using one of AndroScience’s lead compounds, ASC-J9^®, to treat Kennedy Disease (an inherited Motor Neuron Disorder) in an animal model by Dr. Chawnshang Chang (Professor, University of Rochester) and his colleagues has been published in the March 2007 issue of NATURE MEDICINE. (vol: 13, number 3, page 348).




February 2007 - AndroScience Corporation begins Clinical Trials in Humans with Acne Vulgaris

AndroScience Corporation (ASC), a San Diego based biotech company, launched Phase I Human Clinical Trials for Acne Indication in February 2007.